Your browser doesn't support javascript.
loading
LncRNA RPARP-AS1 promotes the progression of osteosarcoma cells through regulating lipid metabolism.
Cai, Feng; Liu, Luhua; Bo, Yuan; Yan, Wenjing; Tao, Xuchang; Peng, Yuanxiang; Zhang, Zhiping; Liao, Qi; Yi, Yangyan.
Afiliación
  • Cai F; The Third Affiliated Hospital of Nanchang University, North 128 Xiangshan Road, Nanchang, Jiangxi, 330008, P.R. China.
  • Liu L; Department of Orthopedics, The First Hospital of Nanchang, North 128 Xiangshan Road, Nanchang, Jiangxi, 330008, P.R. China.
  • Bo Y; The Third Affiliated Hospital of Nanchang University, North 128 Xiangshan Road, Nanchang, Jiangxi, 330008, P.R. China.
  • Yan W; The Third Affiliated Hospital of Nanchang University, North 128 Xiangshan Road, Nanchang, Jiangxi, 330008, P.R. China.
  • Tao X; The Third Affiliated Hospital of Nanchang University, North 128 Xiangshan Road, Nanchang, Jiangxi, 330008, P.R. China.
  • Peng Y; The Third Affiliated Hospital of Nanchang University, North 128 Xiangshan Road, Nanchang, Jiangxi, 330008, P.R. China.
  • Zhang Z; Department of Orthopedics, The First Hospital of Nanchang, North 128 Xiangshan Road, Nanchang, Jiangxi, 330008, P.R. China.
  • Liao Q; The Third Affiliated Hospital of Nanchang University, North 128 Xiangshan Road, Nanchang, Jiangxi, 330008, P.R. China.
  • Yi Y; The Third Affiliated Hospital of Nanchang University, North 128 Xiangshan Road, Nanchang, Jiangxi, 330008, P.R. China.
BMC Cancer ; 24(1): 166, 2024 Feb 02.
Article en En | MEDLINE | ID: mdl-38308235
ABSTRACT
Osteosarcoma (OS) is a highly malignant tumor, and its dysregulated lipid metabolism is associated with tumorigenesis and unfavorable prognosis. Interestingly, long noncoding RNAs (lncRNAs) have emerged as pivotal regulators of lipid metabolism, exerting notable impacts on tumor proliferation. Nevertheless, the involvement of RPARP-AS1, a novel lipid metabolism-associated lncRNA, remains unexplored in the context of OS. This study aims to identify functionally relevant lncRNAs impacting OS proliferation and lipid metabolism and seeks to shed light on the upstream regulatory mechanisms governing lipogenic enzyme activity. Based on comprehensive bioinformatic analysis and the establishment of a risk model, we identified seven lncRNAs significantly associated with clinical characteristics and lipid metabolism-related genes in patients with OS. Among these, RPARP-AS1 was selected for in-depth investigation regarding its roles in OS proliferation and lipid metabolism. Experimental techniques including RT-qPCR, Western blot, cell viability assay, assessment, and quantification of free fatty acids (FFAs) and triglycerides (TGs) were utilized to elucidate the functional significance of RPARP-AS1 in OS cells and validate its effects on lipid metabolism. Manipulation of RPARP-AS1 expression via ectopic expression or siRNA-mediated knockdown led to alterations in epithelial-mesenchymal transition (EMT) and expression of apoptosis-associated proteins, thereby influencing OS cell proliferation and apoptosis. Mechanistically, RPARP-AS1 was found to augment the expression of key lipogenic enzymes (FABP4, MAGL, and SCD1) and potentially modulate the Akt/mTOR pathway, thereby contributing to lipid metabolism (involving alterations in FFA and TG levels) in OS cells. Collectively, our findings establish RPARP-AS1 as a novel oncogene in OS cells and suggest its role in fostering tumor growth through the enhancement of lipid metabolism.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Óseas / Osteosarcoma / MicroARNs / ARN Largo no Codificante Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Óseas / Osteosarcoma / MicroARNs / ARN Largo no Codificante Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article